Novartis AG CEO Vas Narasimhan has thrown his weight behind the antimalarial hydroxychloroquine as potentially the best option to tackle the symptoms of the coronavirus in the short term.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?